Blueprint Medicines shares owned by Mraz, Amerine & Associates
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Mraz, Amerine & Associates
from 13F filings
Historical chart of Mraz, Amerine & Associates investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Mraz, Amerine & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by Mraz, Amerine & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $466k | 5.3k | 87.22 |
| 2024-09-30 | $535k | 5.8k | 92.50 |
| 2024-06-30 | $641k | 5.9k | 107.78 |
| 2024-03-31 | $576k | 6.1k | 94.86 |
| 2023-12-31 | $582k | 6.3k | 92.24 |
| 2023-09-30 | $317k | 6.3k | 50.22 |
| 2023-06-30 | $415k | 6.6k | 63.20 |
| 2023-03-31 | $296k | 6.6k | 44.99 |
More positions owned by Mraz, Amerine & Associates
View all positions for Mraz, Amerine & Associates